Maria Fernanda Saavedra Chacón

Internal medicine Dr, Hepatologist #LiverTwitter #LiverX

[Elliot Tapper @ebtapper]

👑

[Hepatology Communications @HepCommJournal]

📑 Screening and management of portal hypertension and varices in #cirrhosis: Expert perspectives‼️
#OpenAccess #LiverX

https://t.co/wXAXo6uFYb

[JHEP Reports @JHEP_Reports]

🟣IMAT-#HCC model: Liver stiffness–enhanced integrated risk stratification for #HCC recurrence after resection
🔓#OpenAccess at👉https://t.co/i0QdtTwJI7

#HCC #LiverTwitter #LiverHealth #LiverX

[Hepatology Communications @HepCommJournal]

📄 High frequency of ABCB4 and 
ABCB11 gene variants in adult patients with idiopathic chronic or recurrent #cholestasis❕
#OpenAccess #LiverX

https://t.co/NGRog1RbLG

[Elliot Tapper @ebtapper]

It runs in families.

Dr. Tu shows that having a PARENT die from alcohol-related liver diseases puts the CHILD at higher risk of alcohol misuse and worse outcomes from alcohol-associated hepatitis

Nature or Nurture? The answer is yes.

[Maria Fernanda Saavedra Chacón @mafe0037]

@AASLDtweets D

[Shamsher Chauhan @doctorboletoh]

So @ChatGPTapp & @claudeai taught me a lot about use of CRRT from the Hepatologist point of view. Dear colleagues who use this modality for ALF/ACLF routinely would you please like to add your inputs to it #GITwitter

[Hong Jae Chon @hongjaechon]

❓ What best predicts liver dysfunction after locoregional therapy in HCC patients? @LTxJournal
👉 Liver function scores (MELD, MELD-Na, bilirubin) outperformed tumor and demographic variables, with MELD showing the highest discrimination for both 30- and 90-day outcomes. 
👉 Retrospective cohort study by Agins et al. has recently been published in Liver Transplantation. 
Predicting Severe Liver Dysfunction After Locoregional Therapy for HCC 
DOI: https://t.co/Fcm1pYfMwD

@AASLDtweets @ILCAnews @EASLnews @myESMO
 #HCC  #LocoregionalTherapy #MELD #LiverDysfunction

[Joaquín Primo @joaprimo]

Definition, diagnosis, and treatment of primary biliary cholangitis - autoimmune hepatitis (PBC-AIH) variant: An international expert delphi consensus

@HEP_Journal 🔒

https://t.co/rq6UWXhLnu

#PBC #AIH #LiverX #LiverTwitter

[Asociación Española para el Estudio del Hígado @AEEHLiver]

📢 ¡Artículo de acceso gratuito en nuestra revista 'Gastroenterología y Hepatología'!

📕Nuevo "Documento de consenso sobre el diagnóstico, manejo y tratamiento de la infección crónica por el virus de la #hepatitisB y por el virus de la #hepatitisD en España".

🔎Coordinado por @SaSi_Lens. Accede aquí: ➡️ https://t.co/C7ttGjdsIa

[Joaquín Primo @joaprimo]

Is liver steatosis a disease or the emperor’s new clothes?

🔓@JHepatology https://t.co/tZc7wP3KHM

#MASLD #LiverTwitter #LiverX #OpenAccess

[Asociación Española para el Estudio del Hígado @AEEHLiver]

📢¡Última llamada!
🧑‍💻Recordamos que este miércoles 22 de abril celebraremos el webinar del Registro #ColHai "Fatiga en la Colangitis Biliar Primaria: ¿Un síntoma relevante en la práctica clínica?"

👥Con la moderación de @macarlotal y la participación de los expertos @SergioRTajes, Palak Trivedi (@CholestasisDoc), @Indhira0224 y @E_ferreiroperez.
¡Inscríbete aquí!➡️ https://t.co/bAdrI7Cx3q
#formaciónAEEH #RegistroColHai #CBP

[JHEP Reports @JHEP_Reports]

🟣Management of obesity in advanced chronic liver disease

🔓#OpenAccess at 👉https://t.co/T8gGQp1WOs

#LiverX #LiverDisease #LiverHealth

[Javier Crespo @DrJavierCrespo]

The infradiagnosis is the norm in alcohol consumption and for this reason, the MetaLD and ALD diagnoses are clearly lower than the actual ones.

[Arndt Vogel @ArndtVogel]

Clinical guideline for the diagnosis and treatment of fibrolamellar carcinoma
@HEP_Journal
https://t.co/jm0cOxRL0o
👏Timely guideline
👉still very difficult to treat tumor
@ASCO @myESMO @EASLnews @ILCAnews

[Maria Fernanda Saavedra Chacón @mafe0037]

8 de marzo!🌹

[Maria Fernanda Saavedra Chacón @mafe0037]

Aprendiendo de los mejores! @fcardioinfantil #preceptorshiphepatocarcinoma

[Rohit Loomba @DrLoomba]

Why should we screen for liver fibrosis in T2DM? @DrHuangDQ @DanielJDrucker @DarrellIssa @EASLnews
Type 2 diabetes, hepatic decompensation, and HCC in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis - https://t.co/C4GsYo7Jnx

[Elliot Tapper @ebtapper]

Cirrhosis is the most potent risk factor for death from legionella pneumonia

[Joaquín Primo @joaprimo]

BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update.

@BCLC_group @JHepatology

🔓https://t.co/sIglf6RUJ9

#HCC #BCLC #LiverTwitter #LiverX